Skip to content

QLY BIOTECH GROUP CORP.

CIK 0001787123

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q2 Apr 2023
Net Income (TTM)
−$25.85K
+52.2% YoY Q2 Apr 2023
EPS Diluted (TTM)
—
Q2 Apr 2023
Gross Margin
—
Q2 Apr 2023
Operating Margin
—
Q2 Apr 2023
Net Margin
—
Q2 Apr 2023
Free Cash Flow (TTM)
−$12.11K
Q2 Apr 2023
Cash
$0
Q2 Apr 2023
Total Debt
—
Q2 Apr 2023
Shares Outstanding
3.9M sh
Q2 Apr 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings